MedTrace Logo

Investigation of Plasma Mitochondrial DNA Level in Septic Patients

NCT02019992 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2013-12-24

No results posted yet for this study

Summary

To determine the plasma levels of mtDNA in ICU department patients with and without sepsis and evaluate their association with severity, systemic inflammation and outcomes. Plasma from control, septic and severe septic patients will be collected. The level of mtDNA and systemic cytokine will be measured.

Conditions

Sponsors & Collaborators

  • Central South University

    lead OTHER

Principal Investigators

  • lemeng zhang, md · Central South University

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-09-30
Primary Completion
2015-01-31
Completion
2015-02-28

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02019992 on ClinicalTrials.gov